BioTime (BTX) Posts Q3 EPS of 30c
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
BioTime (NYSE: BTX) reported Q3 EPS of $0.30, which may not compare with the analyst estimate of ($0.14). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.23 million.
Profitability was largely due to a fain on equity method investment in Asterias at fair value.
For earnings history and earnings-related data on BioTime (BTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Toro Company (TTC) Tops Q4 EPS by 6c
- KLX, Inc. (KLXI) Tops Q3 EPS Views
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!